155 related articles for article (PubMed ID: 38192997)
1. Competing risk analysis of cardiovascular death in breast cancer: evidence from the SEER database.
He J; Wang S; Liu H; Duan C; Zhang H; Wen F; Zhang C
Transl Cancer Res; 2023 Dec; 12(12):3591-3603. PubMed ID: 38192997
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Mortality Risk in Patients with Bladder Cancer: A Population-Based Study.
Wang S; Ge C; Zhang J
J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005419
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Cardiovascular-Specific Mortality in Patients With Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Study.
Alhadeethi A; Atia A; Alkhawaldeh IM; Ibrahim AA; Afifi E; Elwekel A; Nouh A; Morsi MH
Cureus; 2023 Dec; 15(12):e51279. PubMed ID: 38288190
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.
Yao H; Shi H; Fan M; Yuan L; Lin R
Oxid Med Cell Longev; 2023; 2023():3619306. PubMed ID: 36825080
[TBL] [Abstract][Full Text] [Related]
5. The Association between ER, PR, HER2, and ER-/PR+ Expression and Lung Cancer Subsequent in Breast Cancer Patients: A Retrospective Cohort Study Based on SEER Database.
Shao HY; Hao BT; Gao FX
Breast J; 2023; 2023():7028189. PubMed ID: 38021219
[TBL] [Abstract][Full Text] [Related]
6. Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: A SEER database analysis.
Xing H; Wu C; Zhang D; Zhang X
Medicine (Baltimore); 2023 Oct; 102(40):e35104. PubMed ID: 37800780
[TBL] [Abstract][Full Text] [Related]
7. Long-term cardiovascular mortality risk in patients with bladder cancer: a real-world retrospective study of 129,765 cases based on the SEER database.
Liao J; Zhou Z
Front Cardiovasc Med; 2023; 10():1142417. PubMed ID: 38028470
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular-specific mortality among multiple myeloma patients: a population-based study.
Yin X; Fan F; Zhang B; Hu Y; Sun C
Ther Adv Hematol; 2022; 13():20406207221086755. PubMed ID: 35387110
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis.
Sun S; Wang W; He C
Oxid Med Cell Longev; 2021; 2021():9985814. PubMed ID: 34257826
[TBL] [Abstract][Full Text] [Related]
10. Competing risk analysis of cardiovascular death in patients with primary gallbladder cancer.
Chen C; Xu F; Yuan S; Zhao X; Qiao M; Han D; Lyu J
Cancer Med; 2023 Feb; 12(3):2179-2186. PubMed ID: 35920057
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Cardiovascular Mortality among 80,042 Older Patients with Bladder Cancer.
Guan T; Su M; Luo Z; Peng W; Zhou R; Lu Z; Feng M; Li W; Teng Y; Jiang Y; Ou C; Chen M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230496
[TBL] [Abstract][Full Text] [Related]
12. High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid.
Wang S; Ge C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10203-10215. PubMed ID: 37270459
[TBL] [Abstract][Full Text] [Related]
13. Association of hormone receptor status with cardiovascular disease mortality in 399,209 patients with stage I to III breast cancer: A population-based study.
Lai Z; Wang L; Liao X; Chen Y; Liu C; Wang C; He J
Medicine (Baltimore); 2022 Nov; 101(46):e31911. PubMed ID: 36401434
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
15. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race.
Zhou J; Cueto J; Ko NY; Hoskins KF; Nabulsi NA; Asfaw AA; Hubbard CC; Mitra D; Calip GS; Law EH
Breast; 2021 Oct; 59():367-375. PubMed ID: 34419726
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease related death among patients with esophagus cancer: A population-based competing risk analysis.
Xia Y; Lin M; Huang J; Fan L
Front Oncol; 2022; 12():976711. PubMed ID: 36185282
[TBL] [Abstract][Full Text] [Related]
17. Chronic Obstructive Pulmonary Disease Mortality in Bladder Cancer Patients: A SEER-Based Competing Risk Analysis.
Wang S; Ge C
Urol J; 2024 May; 21(3):146-154. PubMed ID: 37727915
[TBL] [Abstract][Full Text] [Related]
18. Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events.
Hershman DL; Accordino MK; Shen S; Buono D; Crew KD; Kalinsky K; Trivedi MS; Hur C; Hu J; Unger JM; Wright JD
Cancer; 2020 Apr; 126(7):1541-1549. PubMed ID: 31913500
[TBL] [Abstract][Full Text] [Related]
19. Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
Int J Epidemiol; 2019 Dec; 48(6):1897-1905. PubMed ID: 31155644
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study.
Luo Z; Chi K; Zhao H; Liu L; Yang W; Luo Z; Liang Y; Zeng L; Zhou R; Feng M; Li Y; Hua G; Rao H; Lin X; Yi M
Front Cardiovasc Med; 2023; 10():1130691. PubMed ID: 37614944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
